Latest California Healthline Stories
Providence St. Joseph Health System Merger Creates $100 Million Mental Health Initiative
$30 million is set to be earmarked for mental health counseling and research in California.
Hospital Workers Union Pulls California Ballot Measure On Hospital Exec Pay
The proposed initiative, which had enough signature to qualify for the November ballot, would have limited the annual pay of hospital executives to $450,000.
California Nurse Practitioners Lose Battle For Independent Practice, Again
Physicians remain opposed to removing supervision
Revamp Of State Program For Medically Fragile Kids Moves Forward In Legislature
Some parents and advocates say they now support the measure after changes were made to address their concerns.
California Drug Price Transparency Bill Clears Key Committee
The controversial measure was amended to address drugmakers’ concerns; some lawmakers were confused by the legislation.
California Regulators’ Split View of Health Insurance Mergers
California’s insurance commissioner, Dave Jones, and the Department of Managed Health Care’s Shelley Rouillard have opposing views of at least one major insurance company merger proposal. California Healthline’s Chad Terhune recently discussed the state’s merger landscape on Connecticut Public Radio station WNPR.
California Drug Price Measure Fiercely Opposed By Pharmaceutical Industry
Proposed legislation would require drugmakers to disclose and justify price hikes. The industry has taken to Facebook and Twitter, warning that the proposal could lead to medication shortages in some regions of the state.
California Insurance Commissioner Weighs In Against Aetna-Humana Deal
Commissioner says $37 billion deal would stifle market competition, raise health insurance rates and reduce access to care.
As Marijuana Legalization Initiative Heads For California Ballot, Health Groups Weigh In
Health experts remain divided on legalizing marijuana for recreational use.
Medi-Cal To Spend Nearly $1 Billion On Hepatitis C Drugs Next Year
Costly meds will be discussed at lawmaker hearing on controversial drug price transparency bill.